Laryngology

The Evolution and Outcomes of the Maddern Procedure for the Treatment of Subglottic Stenosis

The Maddern Procedure, a novel, minimally invasive technique to treat subglottic stenosis, has been gaining acceptance in academic centers. The study below describes the technique, as well as shares insights on its evolution over the first 28 patient cases performed at the Cleveland Clinic.

A prospective case-series cataloged descriptive technique modifications for the procedure and was developed after surgeons accumulated and followed a patient cohort for 6 years with a minimum of 2 years of follow-up care (11/2015-11/2021). Main outcomes examined included changes to surgical indications, complications, and post-operative results using validated measures of voice and breathing.

Complete resection of subglottic scaring was performed, at first transcervically (2 patients), then transorally (26 patients). Successful performance of the procedure occurred in all patients without complications, with either successful decannulation of previously existing tracheotomies or removal of perioperative tracheotomies. Buccal grafts in 8 patients replaced skin grafts as the graft of choice. Although high subglottic disease was first thought to be a contraindication, superior results became evident in cases of high stenosis rather than disease that included the upper trachea, with 4 out of 26 patients requiring subsequent tracheal resection or tracheal dilation. Of the 22 remaining patients, 19 had successful arresting of restenosis, with 2/22 undergoing subsequent cricotracheal resection, and 1patient requiring subglottic dilation. Overall, 19/26 (73 percent) patients undergoing the Maddern procedure had objectively favorable outcomes, with 24/26 (92 percent) reporting that if they had to do it all over, they would make the same decision and select to undergo the procedure again.

Although technically challenging, full-thickness mucosal resection and relining of the subglottis is a developing technique that is a safe procedure with favorable patient outcomes that address the recurrent nature of the disease.

Outcome Measures

Patient

#

Months

f/u

Hosp

LOS

Sub

Rx

Sub surg interv monthsVHI-10PCSMCS

Improve

1-10

Again?

Y/N

1763SD1360.031.510Y
2752062.722.710Y
3711061.530.610Y
4691256.460.010Y
5682054.140.410Y
6676656.762.10Y
7601TR27056.762.410Y
8581257.046.8107
9581048.961.19Y
10573253.563.410Y
11571256.762.410Y
125513233.019.38Y
13551TR12053.956.29Y
14551CTR263749.147.02N
15552032.963.810Y
165511632.945.99Y
17541850.942.010Y
185311556.157.27Y
19531TD53046.242.24Y
20523042.337.48Y
21512TD9057.857.18Y
22503552.559.110Y
23461052.857.110Y
24434CTR61257.554.25N
25402055.162.510Y
26395SD2152.251.02Y
27312957.554.29Y
28273452.256.89Y

Number of months of follow-up, length of hospital stay (days), subsequent procedures including tracheal resection (TR), cricotracheal resection (CTR), tracheal dilation (TD), or subglottic dilation (SD), number of months interval from Maddern to subsequent surgery, VHI-10 score at followup, SF12v2 Physical Component Score, SF12v2 Mental Component Score. The patients' subjective score of Maddern procedure improving breathing quality (1 minimally–10 maximally), and yes/no answer to “would you have gone through the Maddern procedure knowing what you know now?”